TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MDNA Stock 12 Month Forecast
Average Price Target
C$5.99
▲(558.24%Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Medicenna Therapeutics Corp in the last 3 months. The average price target is C$5.99 with a high forecast of C$8.23 and a low forecast of C$3.75. The average price target represents a 558.24% change from the last price of C$0.91.
Medicenna Therapeutics has elegant science, Research Capital saysUddin said the data strengthens the case for MDNA11 as a leading next-generation IL-2 therapy in solid tumours.
We believe the futility hurdle in r/r anal cancer is ORR of >20%. Prior clinical trials evaluating CPIs in anal cancer have shown ORR of 10-14% [S.Rao, J.-P.Spano, et al. ESMO Open. 2022, Vol. 7(4); A. Marabelle, J.-P. Delord, et al. Lancet, 2022, Vol. 7(5); S. Lonardi, F. Pietrantonio, et al. J Immunother Cancer. 2021, Vol. 9(11)].
Medicenna Therapeutics has elegant science, Research Capital saysUddin said the data strengthens the case for MDNA11 as a leading next-generation IL-2 therapy in solid tumours.
We believe the futility hurdle in r/r anal cancer is ORR of >20%. Prior clinical trials evaluating CPIs in anal cancer have shown ORR of 10-14% [S.Rao, J.-P.Spano, et al. ESMO Open. 2022, Vol. 7(4); A. Marabelle, J.-P. Delord, et al. Lancet, 2022, Vol. 7(5); S. Lonardi, F. Pietrantonio, et al. J Immunother Cancer. 2021, Vol. 9(11)].
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +20.20% per trade.
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +58.53% per trade.
Copying Andre Uddin's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +205.04% per trade.
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +25.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MDNA Analyst Recommendation Trends
Rating
Apr 24
Aug 24
Nov 24
Dec 24
Apr 25
Strong Buy
5
3
3
3
5
Buy
1
2
2
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
5
5
5
6
In the current month, MDNA has received 6Buy Ratings, 0Hold Ratings, and 0Sell Ratings. MDNA average Analyst price target in the past 3 months is 5.99.
Each month's total comprises the sum of three months' worth of ratings.
MDNA Financial Forecast
MDNA Earnings Forecast
Next quarter’s earnings estimate for MDNA is -C$0.06 with a range of -C$0.07 to -C$0.05. The previous quarter’s EPS was -C$0.07. MDNA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 43.48% of the time in the same period. In the last calendar year MDNA has Outperformed its overall industry.
Next quarter’s earnings estimate for MDNA is -C$0.06 with a range of -C$0.07 to -C$0.05. The previous quarter’s EPS was -C$0.07. MDNA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 43.48% of the time in the same period. In the last calendar year MDNA has Outperformed its overall industry.
No data currently available
MDNA Sales Forecast
Next quarter’s sales forecast for MDNA is C$0.00 with a range of C$0.00 to C$0.00. The previous quarter’s sales results were C$0.00. MDNA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 49.57% of the time in the same period. In the last calendar year MDNA has Preformed in-line its overall industry.
Next quarter’s sales forecast for MDNA is C$0.00 with a range of C$0.00 to C$0.00. The previous quarter’s sales results were C$0.00. MDNA beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 49.57% of the time in the same period. In the last calendar year MDNA has Preformed in-line its overall industry.
MDNA Stock Forecast FAQ
What is TSE:MDNA’s average 12-month price target, according to analysts?
Based on analyst ratings, Medicenna Therapeutics Corp’s 12-month average price target is 5.99.
What is TSE:MDNA’s upside potential, based on the analysts’ average price target?
Medicenna Therapeutics Corp has 558.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TSE:MDNA a Buy, Sell or Hold?
Medicenna Therapeutics Corp has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Medicenna Therapeutics Corp’s price target?
The average price target for Medicenna Therapeutics Corp is 5.99. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is C$8.23 ,the lowest forecast is C$3.75. The average price target represents 558.24% Increase from the current price of C$0.91.
What do analysts say about Medicenna Therapeutics Corp?
Medicenna Therapeutics Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of TSE:MDNA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.